Amplexa Genetics A/S

18/03/2026

Planning a family is a deeply personal experience. At Amplexa Genetics, we offer comprehensive genetic fertility tests designed for private individuals and couples who want to better understand their options and risks and take informed steps on their path to parenthood.

Before starting a family, it’s important to understand the genetic risks that might affect your future children.

Amplexa’s genetic tests are suitable for both individuals and couples, making it easier to look at the bigger picture together. The testing process is simple with clear instructions and no clinical setting required. Results are presented in an easy-to-understand format, helping you focus on what matters most.

Read more here: https://amplexa.com/for-patients/

17/12/2025

Match4Life is a genetic test designed to help couples or individuals who are planning to conceive, ensuring they are genetically compatible and minimizing the risk of passing on inherited conditions.

Before using Match4Life, both individuals (or partners) need to undergo a carrier test. This test checks for genetic mutations that might lead to inherited conditions. By screening both individuals, Match4Life ensures that both are not carriers of the same genetic mutation, which could increase the risk of passing on a genetic disorder to their children. This helps make informed decisions and reduce the chances of having a child affected by a genetic condition.

Read more at: https://amplexa.com/professional/match4life

14/10/2025

30/04/2024

We just wrapped up a three-day congress from April 25-27, in the beautiful Punta Cana, Dominican Republic 🌍
This year, the Congress of the Central American and Caribbean Region of the Latin American Network for Assisted Reproduction ( ) brought together experts and professionals from over 40 Accredited Assisted Reproduction Centers across Latin America.
From Colombia to Venezuela and from Costa Rica through to Honduras, Panama, and our host, the Dominican Republic, we've connected a community dedicated to advancing science and excellence in assisted 👩‍🔬👶
We were sharing cutting-edge knowledge and enriching experiences, strengthening our commitment to driving standards and improving patient care across the region.
Cindy Barrios, our local representative for Central America and the Caribbean, played a pivotal role in sharing insights and forging valuable connections by meeting with our clients🤝

15/04/2024

We recently showed our pioneering work within reproductive genetics at the Congresso Brasileiro 2024 CBPN e REDLARA, Brazil. This event drew together over 400 fertility specialists from across the region, emphasizing its prominence within the field 👩‍🔬 👩‍⚕️
Our CEO Hans Atli Dahl presented "Non-invasive PGT-A: Potential and Promise" focusing on the latest non-invasive preimplantation genetic testing for aneuploidies (niPGT-A), a topic of significant interest to the attendees.
The Red Latinoamericana de Reproducción Asistida (REDLARA), unites over 90% of Latin America's assisted reproduction centers, including 72 accredited centers in Brazil, facilitating an ideal platform for Amplexa Genetics to share and collaborate with leading specialists in the field.
Amplexa Genetics is proud to have contributed to such a pivotal gathering, further solidifying our commitment to advancing reproductive health and genetics across Latin America 👶

19/12/2023

As we bid farewell to the year 2023, we extend heartfelt thanks to our customers, collaborators, R&D funders, and everyone else who have contributed to a great year at Amplexa!
At Christmas, it is important to remember and support those in need. In our daily work, we contribute to the creation of healthy, new life, but we are equally dedicated to support children facing a different journey—their encounters with hospital services during challenging times. Therefore, we are proud to again this year stand by Danske Hospitalsklovne bringing a touch of joy 🤹‍♂️🏥
As we step into a new chapter, let's carry the spirit of gratitude and collaboration forward. Here's to a fantastic year behind us and an even more promising one ahead! 🎉✨

27/11/2023

Christina Dühring Fenger was representing Amplexa Genetics at the exciting and interactive NIHR/MRC mTOR Pathway Diseases node kick-off event in London on November 24th. Here, we had the opportunity to meet with colleagues and potential collaborators, including doctors and researches to discuss the diagnosis of patients with focal epilepsy.

During the event, Joseph Matthew Bateman and Laura Mantoan were pleased to announce that they have received a grant of £1.2 million from MRC for research on brain-specific somatic variants in mTOR pathway genes with Amplexa Genetics A/S as a partner🧠💡 This funding aims to explore the potential development of focal epilepsy.

The gathering provided a valuable platform for networking and fostering collaborations in the field of epilepsy research. Amplexa Genetics looks forward to contributing to advancements in understanding and addressing mTOR pathway diseases through ongoing partnerships and research initiatives 🌐🤝

18/09/2023

Recently, we participated in the III SAEC Congress 2023, Buenos Aires, Argentina🧬👶

This event brought together leading experts from various disciplines to examine the ever-evolving world of assisted reproduction from an interdisciplinary perspective.

At Amplexa Genetics, we were proud to contribute to the discussions that are shaping the future of assisted reproduction. Our commitment to advancing the field through cutting-edge genetic solutions was well-received and greatly appreciated by fellow experts💪🧬

Our dedicated Amplexa representatives, Laura Garcia and Lizbeth Godoy, participated in the congress, fostering valuable connections, exchanging insights, and engaging in meaningful conversations about the direction of reproductive medicine🤝👩‍⚕️👨‍⚕️

06/09/2023

We're excited to welcome two exceptional new team members to Amplexa Genetics!

Rebecca Freitag joins us with a Master's degree in Computational Biomedicine from SDU, and is originally from Germany. She's a valuable addition to our bioinformatics department, bringing expertise and enthusiasm to advance our research.

Ida Marie Nygaard, a talented bioanalyst, recently joined us after gaining valuable experience in molecular pathology and PCR-based techniques. Her passion for genetics and molecular biology enriches our team's capabilities and knowledge base.

We look forward to their contributions at Amplexa – a warm welcome to both of you!

05/09/2023

We're excited to share the highlights from our recent event where we gathered local politicians to discuss the future of the Life Science industry on Fyn and Sønderjylland.

Our event aimed to address these concerns and engage local politicians in finding solutions that can elevate Fyn and Sønderjylland to the same level as Copenhagen and Aarhus. At the core of this effort is the creation of local jobs in the Life Science industry. In this aspect, the news about Novo Nordisk planning to build a new production plant in Odense marks a significant step forward for our region in the Life Science sector. However, as we celebrate this major milestone, it's crucial to remember that small and medium-sized enterprises (SMEs) remain the backbone of our local Life Science ecosystem. Supporting them is essential to ensure the sustained growth and innovation of the industry.

The goal is to bolster the entire Danish Life Science industry, where the conditions for development, innovation, and growth are ripe. This is particularly true on Fyn, where we must adjust the framework to accommodate the needs of small businesses and provide opportunities for SDU graduates to remain in the local area after completing their education.

Life Science may not be everyone's field, but Fyn and Sønderjylland are our shared concerns. We hope that the politicians' attendance and active participation in this meeting will contribute to a brighter future for our local Life Science industry.
Thank you to everyone who joined us! 💪🔬



In attendance were:
👥 Jesper Petersen (S)
👥 Niels Flemming Hansen (KF)
👥 Katrine Daugaard (LA)
👥 Ulf B. Christensen, CEO Pentabase
👥 Leif Hindsted, CEO, Positio ApS
👥 Anders Bojesen, AB Genetik
👥 Diana Arsovic Nielsen, CEO Danish Life Science Cluster
👥 Hans Atli Dahl, CEO Amplexa Genetics A/S

Photo: Jacob Fredegaard

28/08/2023

Amplexa Genetics is thrilled to announce that we have been granted funding from the prestigious Eurostars program as the leading SME for an international collaboration that's set to revolutionize the way we tackle bacterial contamination and spoilage in the food industry!

🔬 Our groundbreaking project is all about advancing the analysis of bacterial growth patterns in an industrial context.

🌍 Foodborne illnesses caused by bacteria are a major public health concern, leading to countless cases, hospitalizations, and food waste annually in Europe. Our project aims to fill the gap in current techniques and bring about a transformative change in the way we understand bacterial growth.

🔍 By redefining the way we study bacterial cultures, we're diving into the intricate details of bacterial growth. This means gaining invaluable insights into the growth patterns of pathogenic bacteria, especially in food production chains.

14/08/2023

🌞This summer, we're thrilled to sponsor the 10th Summer School on 'Epigenomics, Nuclear Receptors, and Disease' on the picturesque Island of Spetses, Greece 🏖️

🧬Renowned experts will guide participants through cutting-edge concepts and methodologies, shedding light on transcription factors, chromatin modifications, and much more.

🔬From engaging workshops to enriching discussions, attendees will have the chance to network and connect against the backdrop of the enchanting Spetses Hotel. This event promises to foster collaboration and inspire new ideas in a relaxed and vibrant atmosphere.

🎓At Amplexa, we are committed to empowering the next generation of scientists through collaborations, student projects, and sponsoring of great educational opportunities such as this.

We wish you a great stay at Spetses!